|国家科技期刊平台
首页|期刊导航|安徽医科大学学报|PCOS患者GnRH-ant方案促排卵过程E2水平变化对助孕结局的影响

PCOS患者GnRH-ant方案促排卵过程E2水平变化对助孕结局的影响OA北大核心CSTPCD

The effect of E2 change on assisted pregnancy outcome in patients with polycystic ovary syndrome during ovulation induction with GnRH-ant protocol

中文摘要英文摘要

目的 研究多囊卵巢综合征(PCOS)患者促性腺激素释放激素拮抗剂(GnRH-ant)方案控制性卵巢刺激(COS)过程中,雌二醇(E2)变化对助孕结局的影响.方法 回顾性研究接受GnRH-ant方案超促排卵并进行体外受精(IVF)或单精子卵胞质内注射(ICSI)后,首次进行冻融胚胎移植(FET)的338例PCOS不孕症患者的临床资料.根据患者应用GnRH-ant第1天和第4天的血清E2水平变化(均在注射GnRH-ant前留取血液样本)进行分组:E2升高组(A组,E2升高超过30%,165例),E2持平组(B组,E2在-30%~30%之间,162例),E2下降组(E2降低超过30%,11例,病例数少未进行统计学分析).分析A、B两组患者的基本资料、促排卵情况、胚胎情况和临床妊娠相关指标的差异.结果 A、B两组患者的年龄、不孕年限、体质量指数(BMI)水平、基础内分泌水平、抗缪勒管激素(AMH)水平等基本资料以及促排卵治疗时的各项数据差异均无统计学意义.在胚胎情况方面,A、B两组患者的受精方式及移植胚胎数差异无统计学意义,但A组患者的获卵总数、正常受精率、优质胚胎数、优胚率均高于B组患者,差异有统计学意义(P<0.05).在临床妊娠情况方面,A、B两组患者的重度卵巢过度刺激综合征(OHSS)发生率差异无统计学意义,但A组患者的临床妊娠率、着床率、活产率均优于B组,差异有统计学意义,A组患者的早期流产率低于B组,差异有统计学意义.结论 选择GnRH-ant方案进行IVF/ICSI-FET的PCOS患者,如果在添加拮抗剂4 d后血E2水平(注射GnRH-ant前留取血液样本)升高>30%,其临床妊娠结局会更好.

Objective To study the effect of changes in estradiol(E2)levels on the reproductive outcomes of pa-tients with polycystic ovary syndrome(PCOS)undergoing controlled ovarian stimulation(COS)with gonadotropin-releasing hormone antagonist(GnRH-ant)protocol.Methods A retrospective study was conducted involving 338 patients with polycystic ovary syndrome(PCOS)infertility who underwent GnRH-ant protocol for controlled ovarian hyperstimulation followed by in vitro fertilization(IVF)or intracytoplasmic sperm injection(ICSI),and subse-quently underwent their first frozen-thawed embryo transfer(FET).The clinical data of these patients were ana-lyzed.Patients were grouped based on the changes in serum E2 levels on the first and fourth day of GnRH-ant ad-ministration(blood samples collected before GnRH-ant injection):the E2 elevation group(Group A,E2 value in-creased more than 30%,165 cases),the E2 stable group(Group B,E2 rate of change was within-30%~30%,162 cases),and the E2 decline group(E2 value declined more than 30%,11 cases,not included in statistical a-nalysis due to small sample size).The differences in demographic characteristics,ovulation induction outcomes,embryo outcomes and clinical pregnancy-related indicators were analyzed between Groups A and B.Results There were no statistically significant differences in basic information such as age,duration of infertility,body mass index(BMI),basal endocrine levels,and anti-Müllerian hormone(AMH)levels between groups A and B.Regarding embryo characteristics,there were no statistically significant differences in fertilization method and number of trans-ferred embryos between groups A and B.However,group A had a higher total number of retrieved oocytes,normal fertilization rate,number of high-quality embryos,and rate of high-quality embryos compared to group B,with sta-tistically significant differences(P<0.05).In terms of clinical pregnancy outcomes,there were no statistically significant differences in the incidence of severe ovarian hyperstimulation syndrome(OHSS)between groups A and B.However,group A had higher rates of clinical pregnancy,implantation,and live birth compared to group B,with statistically significant differences.Group A also had a lower rate of early miscarriage compared to group B,with statistically significant differences.Conclusion Choosing the GnRH-ant protocol for IVF/ICSI-FET in PCOS patients,if the blood E2 level increases by more than 30%after 4 days of adding the antagonist(blood sample col-lected before administering GnRH-ant),the clinical pregnancy outcome will be better.

刘莉;吴彩云;管凌芳;周平

安徽医科大学第一附属医院妇产科,合肥 230032||安徽医科大学附属阜阳医院妇产科,阜阳 236000||国家卫生健康委配子及生殖道异常研究重点实验室,合肥 230032安徽医科大学第一附属医院妇产科,合肥 230032安徽医科大学第一附属医院妇产科,合肥 230032||国家卫生健康委配子及生殖道异常研究重点实验室,合肥 230032||安徽省生命资源保存与人工器官工程技术研究中心,合肥 230032

临床医学

多囊卵巢综合征拮抗剂方案雌二醇妊娠结局

polycystic ovary syndromeantagonist protocolestradiolpregnancy outcome

《安徽医科大学学报》 2024 (006)

961-965 / 5

国家自然科学基金(编号:82301896)

10.19405/j.cnki.issn1000-1492.2024.06.007

评论